EE
Elan Ezickson
Director

Elan Ezickson insider trades: Marinus Pharmaceuticals (MRNS) stock sales

Director, Marinus Pharmaceuticals Last trade Jan 21, 2025 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2010
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Elan reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 21, 2025MRNS↓ Sell$864
Feb 6, 2023MRNS↓ Sell$5K
Jan 28, 2013AVEO↓ Sell$9K
Jan 26, 2012AVEO↓ Sell$15K
Jun 10, 2011AVEO↓ Sell$187K
May 16, 2011AVEO↓ Sell$181K
Apr 11, 2011AVEO↓ Sell$136K
Mar 16, 2011AVEO↓ Sell$108K
Feb 22, 2011AVEO↓ Sell$69K
Jan 10, 2011AVEO↓ Sell$74K
Dec 10, 2010AVEO↓ Sell$71K
Nov 10, 2010AVEO↓ Sell$82K
Oct 4, 2010AVEO↓ Sell$65K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Elan Ezickson's insider trades

Elan Ezickson is a director at Marinus Pharmaceuticals (MRNS). Since Oct 4, 2010, Elan has reported no open-market purchases and 13 sales worth $1.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), option exercises (4 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRNS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.